The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
METRIC: A randomized international study of the antibody-drug conjugate glembatumumab vedotin (GV or CDX-011) in patients (pts) with metastatic gpNMB-overexpressing triple-negative breast cancer (TNBC).
 
Denise A. Yardley
No Relationships to Disclose
 
Michelle E. Melisko
No Relationships to Disclose
 
Andres Forero
Research Funding - Celldex (Inst)
 
Brooke R. Daniel
No Relationships to Disclose
 
Alberto J. Montero
No Relationships to Disclose
 
Troy H. Guthrie
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Vikki A. Canfield
No Relationships to Disclose
 
Catherine Angela Oakman
No Relationships to Disclose
 
Helen K. Chew
No Relationships to Disclose
 
Cristiano Ferrario
Honoraria - Amgen; Sanofi
Consulting or Advisory Role - Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Amgen; Roche Pharma AG; Sanofi
 
Gena H. Volas-Redd
No Relationships to Disclose
 
Robyn R. Young
No Relationships to Disclose
 
Norah Lynn Henry
Research Funding - BioMarin; Celldex; Sanofi
Travel, Accommodations, Expenses - Celldex
 
Lynn Aneiro
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Yi He
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Christopher D. Turner
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Thomas A. Davis
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Linda T. Vahdat
No Relationships to Disclose